TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A 26-week Trial Investigating the Dosing Flexibility, Efficacy and Safety of NN1250 in Subjects With Type 1 Diabetes With a 26-week Extension (Begin™: Flex T1)
Brief Summary: This trial is conducted in Europe and in the United States of America (USA). The aim of this trial is to investigate the efficacy and safety of NN1250 (insulin degludec) in subjects with type 1 diabetes.


Options:
A: Arm Label: Insulin glargine; Type: EXPERIMENTAL; Interventions: Drug: Insulin glargine (HOE901) | Arm Label: NPH insulin; Type: ACTIVE_COMPARATOR; Interventions: Drug: NPH insulin | Intervention Type: DRUG; Name: Insulin glargine (HOE901); Assigned to Arm(s): Insulin glargine | Intervention Type: DRUG; Name: NPH insulin; Assigned to Arm(s): NPH insulin
B: Arm Label: insulin detemir; Type: EXPERIMENTAL; Interventions: Drug: insulin detemir, Drug: insulin aspart | Arm Label: NPH insulin; Type: EXPERIMENTAL; Interventions: Drug: insulin NPH, Drug: insulin aspart | Intervention Type: DRUG; Name: insulin detemir; Assigned to Arm(s): insulin detemir | Intervention Type: DRUG; Name: insulin NPH; Assigned to Arm(s): NPH insulin | Intervention Type: DRUG; Name: insulin aspart; Assigned to Arm(s): NPH insulin, insulin detemir
C: Arm Label: Flex + insulin aspart; Type: EXPERIMENTAL; Interventions: Drug: insulin degludec, Drug: insulin aspart | Arm Label: Fixed + insulin aspart; Type: EXPERIMENTAL; Interventions: Drug: insulin degludec, Drug: insulin aspart | Arm Label: IGlar + insulin aspart; Type: ACTIVE_COMPARATOR; Interventions: Drug: insulin glargine, Drug: insulin aspart | Intervention Type: DRUG; Name: insulin degludec; Assigned to Arm(s): Fixed + insulin aspart, Flex + insulin aspart | Intervention Type: DRUG; Name: insulin glargine; Assigned to Arm(s): IGlar + insulin aspart | Intervention Type: DRUG; Name: insulin aspart; Assigned to Arm(s): Fixed + insulin aspart, Flex + insulin aspart, IGlar + insulin aspart
D: N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Clinical Trial of Restrictive vs. Traditional Blood Transfusion Practices in Burn Patients
Brief Summary: The purpose of this study is to find out if burn injured patients do better receiving fewer blood transfusions than what is traditionally given. We traditionally provide blood transfusions to maintain a hemoglobin level, which is an indicator of the level of red blood cells that carry oxygen in your body, to above 10 g/dl (g/dl stands for grams per deciliter and is the standard measurement used to indicate the level of red blood cells in your blood). However, a preliminary study indicated that maintaining the hemoglobin level to above 7-8 g/dl with less blood transfusion, as compared to a hemoglobin level of 10 g/dl and above, would reduce the occurrence of blood infection, duration on the respirator and length of hospital stay, yet would achieve similar survival in both groups.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Packed Red Blood Cell Transfusion | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Packed Red Blood Cell Transfusion | Intervention Type: PROCEDURE; Name: Packed Red Blood Cell Transfusion; Assigned to Arm(s): 1, 2
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: red blood cell transfusion | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: red blood cell transfusion | Intervention Type: PROCEDURE; Name: red blood cell transfusion; Assigned to Arm(s): 1, 2
C: Arm Label: Liberal; Type: ACTIVE_COMPARATOR; Interventions: Other: Liberal transfusion threshold | Arm Label: Restrictive; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive transfusion threshold | Intervention Type: OTHER; Name: Restrictive transfusion threshold; Assigned to Arm(s): Restrictive | Intervention Type: OTHER; Name: Liberal transfusion threshold; Assigned to Arm(s): Liberal
D: Arm Label: Blood transfusion triggers of 24% hematocrit value; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Blood transfusion at hematocrit value less than 24% | Arm Label: Blood transfusion triggers of 28% hematocrit value; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Blood transfusion at hematocrit value less than 28% | Intervention Type: PROCEDURE; Name: Blood transfusion at hematocrit value less than 24%; Assigned to Arm(s): Blood transfusion triggers of 24% hematocrit value | Intervention Type: PROCEDURE; Name: Blood transfusion at hematocrit value less than 28%; Assigned to Arm(s): Blood transfusion triggers of 28% hematocrit value

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Clinical Trial of Restrictive vs. Traditional Blood Transfusion Practices in Burn Patients
Brief Summary: The purpose of this study is to find out if burn injured patients do better receiving fewer blood transfusions than what is traditionally given. We traditionally provide blood transfusions to maintain a hemoglobin level, which is an indicator of the level of red blood cells that carry oxygen in your body, to above 10 g/dl (g/dl stands for grams per deciliter and is the standard measurement used to indicate the level of red blood cells in your blood). However, a preliminary study indicated that maintaining the hemoglobin level to above 7-8 g/dl with less blood transfusion, as compared to a hemoglobin level of 10 g/dl and above, would reduce the occurrence of blood infection, duration on the respirator and length of hospital stay, yet would achieve similar survival in both groups.


Options:
A: Arm Label: Liberal; Type: ACTIVE_COMPARATOR; Interventions: Other: Liberal transfusion threshold | Arm Label: Restrictive; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive transfusion threshold | Intervention Type: OTHER; Name: Restrictive transfusion threshold; Assigned to Arm(s): Restrictive | Intervention Type: OTHER; Name: Liberal transfusion threshold; Assigned to Arm(s): Liberal
B: Arm Label: Restrictive transfusion strategy; Type: EXPERIMENTAL; Interventions: Procedure: Restrictive transfusion, Biological: red blood transfusion | Arm Label: Liberal transfusion strategy; Type: EXPERIMENTAL; Interventions: Procedure: Liberal transfusion, Biological: red blood transfusion | Intervention Type: PROCEDURE; Name: Restrictive transfusion; Assigned to Arm(s): Restrictive transfusion strategy | Intervention Type: PROCEDURE; Name: Liberal transfusion; Assigned to Arm(s): Liberal transfusion strategy | Intervention Type: BIOLOGICAL; Name: red blood transfusion; Assigned to Arm(s): Liberal transfusion strategy, Restrictive transfusion strategy
C: Arm Label: Single-Unit Blood Transfusion Protocol; Type: ACTIVE_COMPARATOR; Interventions: Biological: Blood Transfusion | Arm Label: Multiple-Unit Blood Transfusion Protocol; Type: ACTIVE_COMPARATOR; Interventions: Biological: Blood Transfusion | Intervention Type: BIOLOGICAL; Name: Blood Transfusion; Assigned to Arm(s): Multiple-Unit Blood Transfusion Protocol, Single-Unit Blood Transfusion Protocol
D: Arm Label: Restrictive transfusion strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive Transfusion Strategy | Arm Label: Liberal transfusion strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Liberal transfusion strategy | Intervention Type: OTHER; Name: Restrictive Transfusion Strategy; Assigned to Arm(s): Restrictive transfusion strategy | Intervention Type: OTHER; Name: Liberal transfusion strategy; Assigned to Arm(s): Liberal transfusion strategy

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Clinical Trial of Restrictive vs. Traditional Blood Transfusion Practices in Burn Patients
Brief Summary: The purpose of this study is to find out if burn injured patients do better receiving fewer blood transfusions than what is traditionally given. We traditionally provide blood transfusions to maintain a hemoglobin level, which is an indicator of the level of red blood cells that carry oxygen in your body, to above 10 g/dl (g/dl stands for grams per deciliter and is the standard measurement used to indicate the level of red blood cells in your blood). However, a preliminary study indicated that maintaining the hemoglobin level to above 7-8 g/dl with less blood transfusion, as compared to a hemoglobin level of 10 g/dl and above, would reduce the occurrence of blood infection, duration on the respirator and length of hospital stay, yet would achieve similar survival in both groups.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Packed Red Blood Cell Transfusion | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Packed Red Blood Cell Transfusion | Intervention Type: PROCEDURE; Name: Packed Red Blood Cell Transfusion; Assigned to Arm(s): 1, 2
B: Arm Label: Haemoglobin (<6.0 mmol/l); Type: ACTIVE_COMPARATOR; Interventions: Other: Blood transfusion | Arm Label: Haemoglobin (< normal range); Type: EXPERIMENTAL; Interventions: Other: Blood transfusion | Intervention Type: OTHER; Name: Blood transfusion; Assigned to Arm(s): Haemoglobin (< normal range), Haemoglobin (<6.0 mmol/l)
C: Arm Label: Low transfusion trigger; Type: ACTIVE_COMPARATOR; Interventions: Biological: red blood cell transfusion | Arm Label: High transfusion trigger; Type: ACTIVE_COMPARATOR; Interventions: Biological: red blood cell transfusion | Intervention Type: BIOLOGICAL; Name: red blood cell transfusion; Assigned to Arm(s): High transfusion trigger, Low transfusion trigger
D: Arm Label: Liberal; Type: ACTIVE_COMPARATOR; Interventions: Other: Liberal transfusion threshold | Arm Label: Restrictive; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive transfusion threshold | Intervention Type: OTHER; Name: Restrictive transfusion threshold; Assigned to Arm(s): Restrictive | Intervention Type: OTHER; Name: Liberal transfusion threshold; Assigned to Arm(s): Liberal

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Clinical Trial of Restrictive vs. Traditional Blood Transfusion Practices in Burn Patients
Brief Summary: The purpose of this study is to find out if burn injured patients do better receiving fewer blood transfusions than what is traditionally given. We traditionally provide blood transfusions to maintain a hemoglobin level, which is an indicator of the level of red blood cells that carry oxygen in your body, to above 10 g/dl (g/dl stands for grams per deciliter and is the standard measurement used to indicate the level of red blood cells in your blood). However, a preliminary study indicated that maintaining the hemoglobin level to above 7-8 g/dl with less blood transfusion, as compared to a hemoglobin level of 10 g/dl and above, would reduce the occurrence of blood infection, duration on the respirator and length of hospital stay, yet would achieve similar survival in both groups.


Options:
A: Arm Label: Liberal; Type: EXPERIMENTAL; Interventions: Drug: red blood cell transfusion trigger | Arm Label: Restrictive; Type: ACTIVE_COMPARATOR; Interventions: Drug: red blood cell transfusion trigger | Intervention Type: DRUG; Name: red blood cell transfusion trigger; Assigned to Arm(s): Liberal, Restrictive
B: Arm Label: Liberal; Type: ACTIVE_COMPARATOR; Interventions: Other: Liberal transfusion threshold | Arm Label: Restrictive; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive transfusion threshold | Intervention Type: OTHER; Name: Restrictive transfusion threshold; Assigned to Arm(s): Restrictive | Intervention Type: OTHER; Name: Liberal transfusion threshold; Assigned to Arm(s): Liberal
C: Arm Label: "liberal" transfusion triggers; Type: EXPERIMENTAL; Interventions: Other: red blood cell transfusion | Arm Label: "restrictive" transfusion triggers; Type: ACTIVE_COMPARATOR; Interventions: Other: red blood cell transfusion | Intervention Type: OTHER; Name: red blood cell transfusion; Assigned to Arm(s): "liberal" transfusion triggers | Intervention Type: OTHER; Name: red blood cell transfusion; Assigned to Arm(s): "restrictive" transfusion triggers
D: Arm Label: Single-Unit Blood Transfusion Protocol; Type: ACTIVE_COMPARATOR; Interventions: Biological: Blood Transfusion | Arm Label: Multiple-Unit Blood Transfusion Protocol; Type: ACTIVE_COMPARATOR; Interventions: Biological: Blood Transfusion | Intervention Type: BIOLOGICAL; Name: Blood Transfusion; Assigned to Arm(s): Multiple-Unit Blood Transfusion Protocol, Single-Unit Blood Transfusion Protocol

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Does Coffee Intake Reduce Postoperative Ileus After Elective Colectomy?
Brief Summary: The purpose of the investigators study is to investigate the effects of coffee on the return of bowel function and appetite, length of hospital stay, and complications after elective open colectomy in a prospective randomized trial. The primary efficacy endpoint is time to first bowel movement.


Options:
A: Arm Label: chewing gum; Type: EXPERIMENTAL; Interventions: Behavioral: gum chewing | Intervention Type: BEHAVIORAL; Name: gum chewing; Assigned to Arm(s): chewing gum
B: Arm Label: 1.; Type: ACTIVE_COMPARATOR; Interventions: Other: Trident sugarless chewing gum. | Arm Label: 2.; Type: PLACEBO_COMPARATOR; Interventions: Other: One control group (these do not chew gum). | Intervention Type: OTHER; Name: Trident sugarless chewing gum.; Assigned to Arm(s): 1. | Intervention Type: OTHER; Name: One control group (these do not chew gum).; Assigned to Arm(s): 2.
C: Arm Label: Treatment arm: coffee; Type: ACTIVE_COMPARATOR; Interventions: Other: Postoperative coffee | Arm Label: Water arm; Type: PLACEBO_COMPARATOR; Interventions: Other: water | Intervention Type: OTHER; Name: Postoperative coffee; Assigned to Arm(s): Treatment arm: coffee | Intervention Type: OTHER; Name: water; Assigned to Arm(s): Water arm
D: Arm Label: major surgery; Type: EXPERIMENTAL; Interventions: Dietary Supplement: olive oil, Dietary Supplement: olive oil and chewing gum, Dietary Supplement: chewing gum, Dietary Supplement: water | Arm Label: minor surgery; Type: EXPERIMENTAL; Interventions: Dietary Supplement: olive oil, Dietary Supplement: olive oil and chewing gum, Dietary Supplement: chewing gum, Dietary Supplement: water | Arm Label: ileostomy and colostomy; Type: EXPERIMENTAL; Interventions: Dietary Supplement: olive oil, Dietary Supplement: olive oil and chewing gum, Dietary Supplement: chewing gum, Dietary Supplement: water | Arm Label: other surgery; Type: EXPERIMENTAL; Interventions: Dietary Supplement: olive oil, Dietary Supplement: olive oil and chewing gum, Dietary Supplement: chewing gum, Dietary Supplement: water | Intervention Type: DIETARY_SUPPLEMENT; Name: olive oil; Assigned to Arm(s): ileostomy and colostomy, major surgery, minor surgery, other surgery | Intervention Type: DIETARY_SUPPLEMENT; Name: olive oil and chewing gum; Assigned to Arm(s): ileostomy and colostomy, major surgery, minor surgery, other surgery | Intervention Type: DIETARY_SUPPLEMENT; Name: chewing gum; Assigned to Arm(s): ileostomy and colostomy, major surgery, minor surgery, other surgery | Intervention Type: DIETARY_SUPPLEMENT; Name: water; Assigned to Arm(s): ileostomy and colostomy, major surgery, minor surgery, other surgery

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Reducing Falls With RENEW in Older Adults Who Have Fallen
Brief Summary: This clinical trial will compare the effects of a high intensity Resistance Exercise via Negative Work (RENEW) vs. Traditional resistance exercise (TRAD) as part of a mult-component exercise and fall-reduction program on muscle conditioning; falling risks; as well as the fall incidence in older adults who have fallen. We anticipate that muscle conditioning will mediate the effect of RENEW on falling risks and fall incidence.


Options:
A: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Other: Fall prevention exercise program | Intervention Type: OTHER; Name: Fall prevention exercise program; Assigned to Arm(s): 2
B: Intervention Type: PROCEDURE; Name: Falls Prevention Program; Assigned to Arm(s): N/A
C: Arm Label: RENEW; Type: EXPERIMENTAL; Interventions: Behavioral: RENEW | Arm Label: TRADITIONAL; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: RENEW; Assigned to Arm(s): RENEW
D: Arm Label: TT+VR; Type: EXPERIMENTAL; Interventions: Other: TT+VR | Arm Label: TT alone; Type: ACTIVE_COMPARATOR; Interventions: Other: TT alone | Intervention Type: OTHER; Name: TT+VR; Assigned to Arm(s): TT+VR | Intervention Type: OTHER; Name: TT alone; Assigned to Arm(s): TT alone

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Assertive Community Treatment (ACT) as Part of Integrated Care Versus Standard Care: a 12-month Trial in Patients With First- and Negatively Selected Multiple-episode Schizophrenia-spectrum Disorders Treated With Quetiapine IR
Brief Summary: The study examined the 12-month effectiveness of continuous therapeutic assertive community treatment (ACT) as part of integrated care (IC) compared to standard care (SC) in a catchment area comparison design in patients with schizophrenia spectrum disorders (SSD) treated with quetiapine IR.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Falls Prevention | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Falls Prevention; Assigned to Arm(s): 1
B: Arm Label: Standard care; Type: EXPERIMENTAL; Interventions: Behavioral: Assertive Community Treatment (ACT) | Intervention Type: BEHAVIORAL; Name: Assertive Community Treatment (ACT); Assigned to Arm(s): Standard care
C: Arm Label: physical activity and nutrition; Type: EXPERIMENTAL; Interventions: Behavioral: Project Fit | Intervention Type: BEHAVIORAL; Name: Project Fit; Assigned to Arm(s): physical activity and nutrition
D: Intervention Type: BEHAVIORAL; Name: In-school Sexual Health Education; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Youth-friendly health services; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Youth condom promotion & distribution; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Community activities related to adolescent sexual health; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin as Monotherapy in the Treatment of Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise
Brief Summary: The purpose of this study is to evaluate the efficacy, safety, and tolerability of 2 different doses of canagliflozin administered as monotherapy compared with placebo in patients with type 2 diabetes mellitus (T2DM) inadequately controlled with diet and exercise.


Options:
A: Arm Label: linagliptin 5 mg; Type: EXPERIMENTAL; Interventions: Drug: linagliptin | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: linagliptin; Assigned to Arm(s): linagliptin 5 mg | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo
B: Arm Label: Canagliflozin 100 mg; Type: EXPERIMENTAL; Interventions: Drug: Canagliflozin | Arm Label: Canagliflozin 300 mg; Type: EXPERIMENTAL; Interventions: Drug: Canagliflozin | Arm Label: Placebo/Sitagliptin; Type: EXPERIMENTAL; Interventions: Drug: Placebo, Drug: Sitagliptin | Intervention Type: DRUG; Name: Canagliflozin; Assigned to Arm(s): Canagliflozin 100 mg, Canagliflozin 300 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo/Sitagliptin | Intervention Type: DRUG; Name: Sitagliptin; Assigned to Arm(s): Placebo/Sitagliptin
C: Arm Label: 0.6 mg + SU; Type: EXPERIMENTAL; Interventions: Drug: sulfonylurea, Drug: liraglutide | Arm Label: 0.9 mg + SU; Type: EXPERIMENTAL; Interventions: Drug: sulfonylurea, Drug: liraglutide | Arm Label: SU Mono - 1; Type: PLACEBO_COMPARATOR; Interventions: Drug: sulfonylurea | Arm Label: SU Mono - 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: sulfonylurea | Intervention Type: DRUG; Name: sulfonylurea; Assigned to Arm(s): 0.6 mg + SU, 0.9 mg + SU, SU Mono - 1, SU Mono - 2 | Intervention Type: DRUG; Name: liraglutide; Assigned to Arm(s): 0.6 mg + SU | Intervention Type: DRUG; Name: liraglutide; Assigned to Arm(s): 0.9 mg + SU
D: Arm Label: Canagliflozin 100 mg; Type: EXPERIMENTAL; Interventions: Drug: Canagliflozin, Drug: Metformin immediate release | Arm Label: Canagliflozin 300 mg; Type: EXPERIMENTAL; Interventions: Drug: Canagliflozin, Drug: Metformin immediate release | Arm Label: Sitagliptin 100 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sitagliptin, Drug: Metformin immediate release | Arm Label: Placebo/Sitagliptin; Type: OTHER; Interventions: Drug: Placebo, Drug: Sitagliptin, Drug: Metformin immediate release | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo/Sitagliptin | Intervention Type: DRUG; Name: Canagliflozin; Assigned to Arm(s): Canagliflozin 100 mg, Canagliflozin 300 mg | Intervention Type: DRUG; Name: Sitagliptin; Assigned to Arm(s): Placebo/Sitagliptin, Sitagliptin 100 mg | Intervention Type: DRUG; Name: Metformin immediate release; Assigned to Arm(s): Canagliflozin 100 mg, Canagliflozin 300 mg, Placebo/Sitagliptin, Sitagliptin 100 mg

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effectiveness of the Liverpool Care Pathway in Improving End of Life Care for Dying Cancer Patients in Hospital. A Cluster Randomised Trial.
Brief Summary: The purpose of this study is to evaluate the effectiveness of the LCP-I Program in improving the quality of end-of-life care provided to cancer patients who die on hospital medical wards as compared to standard healthcare practices.


Options:
A: Arm Label: The LCP-I Program.; Type: EXPERIMENTAL; Interventions: Other: The LCP-I Program | Arm Label: standard healthcare practices; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: The LCP-I Program; Assigned to Arm(s): The LCP-I Program.
B: Arm Label: 001; Type: EXPERIMENTAL; Interventions: Drug: R331333 (referred to as JNS024 ER or CG5503) | Arm Label: 002; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxycodone CR | Intervention Type: DRUG; Name: Oxycodone CR; Assigned to Arm(s): 002 | Intervention Type: DRUG; Name: R331333 (referred to as JNS024 ER or CG5503); Assigned to Arm(s): 001
C: Arm Label: Oxycodone Hydrochloride Tablets; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxycodone | Arm Label: Oxycodone Naloxone Tablets; Type: EXPERIMENTAL; Interventions: Drug: Oxycodone/Naloxone | Intervention Type: DRUG; Name: Oxycodone; Assigned to Arm(s): Oxycodone Hydrochloride Tablets | Intervention Type: DRUG; Name: Oxycodone/Naloxone; Assigned to Arm(s): Oxycodone Naloxone Tablets
D: Arm Label: carboplatin + etoposide + exisulind; Type: EXPERIMENTAL; Interventions: Drug: carboplatin, Drug: etoposide, Drug: exisulind | Intervention Type: DRUG; Name: carboplatin; Assigned to Arm(s): carboplatin + etoposide + exisulind | Intervention Type: DRUG; Name: etoposide; Assigned to Arm(s): carboplatin + etoposide + exisulind | Intervention Type: DRUG; Name: exisulind; Assigned to Arm(s): carboplatin + etoposide + exisulind

Answer: A